Welcome to IgMin Research – an Open Access journal uniting Biology, Medicine, and Engineering. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.
At IgMin Research, we bridge the frontiers of Biology, Medicine, and Engineering to foster interdisciplinary innovation. Our expanded scope now embraces a wide spectrum of scientific disciplines, empowering global researchers to explore, contribute, and collaborate through open access.
Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.
IgMin Publications Inc., Suite 102, West Hartford, CT - 06110, USA
Our mission is to build a collaborative platform that merges expertise for rapid knowledge gains.
Biography
Dr. Shweta Walia is a distinguished Professor of Ophthalmology at MGM Medical College, Indore, where she specializes in cataract surgery, corneal transplantation, glaucoma, pediatric ophthalmology, and medical retina care.
An alumna of MGM Medical College (UG 2003, MS 2007), she also holds an MBA in Hospital Administration from Indore, graduating top of her state . Feeder nurturing medical students and trainees has been a constant throughout her career of over 18 years.
In her current role, Dr. Walia balances teaching, clinical duties, and administrative responsibilities. She serves as the Joint Secretary of the Madhya Pradesh State Ophthalmological Society (MPSOS) and as Resident Coordinator for the World Ophthalmology Society (WOS) in India, reflecting her leadership in professional organizations. Additionally, she holds the science committee chair role at MPSOS Indore.
Dr. Walia’s research demonstrates a strong commitment to ocular public health. Her recent IGMin Research article, “Prevalence of Diabetic Retinopathy among Self‑reported Newly Diagnosed Diabetics,” drawn from a prospective study of 200 patients in Indore, highlights risk factors such as age, gender, hypertension, and family history. This work earned her IGMin’s Certificate of Publication .
Beyond academia, Dr. Walia leads at Sparsh Eye Care (Kanadia Road, Indore), where patient testimonials commend her approachable demeanor and expert treatment, especially in LASIK, cataract, and glaucoma procedures . She is a trusted mentor and advocate for eye care across India.
In all aspects—clinical excellence, teaching, leadership, and research—Dr. Shweta Walia embodies dedication to improving ophthalmic care and outcomes across the region.
Research Interest
Dr. Shweta Walia’s research interests center around enhancing clinical outcomes in ophthalmology through early detection, intervention, and community outreach. She is particularly focused on diabetic retinopathy, conducting prospective studies to identify early-stage prevalence and associated risk factors such as hypertension, family history, and age. Her expertise extends to cataract surgery innovations, glaucoma screening, and LASIK techniques, with a strong emphasis on optimizing visual rehabilitation. She is also interested in ocular surface disorders, pediatric eye care, and preventive ophthalmology—aiming to reduce the incidence of avoidable blindness in underserved populations. As a medical educator and resident coordinator, Dr. Walia also explores ophthalmic training methodologies, contributing to curriculum advancement and professional development in eye care. Her ongoing collaborations with the Madhya Pradesh State Ophthalmological Society (MPSOS) and World Ophthalmology Society (WOS) underscore her commitment to both clinical excellence and academic leadership in the evolving field of ophthalmology.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
Introduction: Diabetic Retinopathy (DR) poses a significant threat to individuals with diabetes, leading to visual impairment and blindness if not promptly addressed. This study focuses on the prevalence of diabetic retinopathy among self-reported newly diagnosed diabetics.Material method: This is a prospective study on 200 self-reported newly diagnosed diabetics from April 2022 to May 2023. Patient data, including complaints, diabetes duration, family history, hypertension, and therapy details, were comprehensively analyzed. Complete Ocular ex...aminations including best-corrected visual acuity, intraocular pressure, slit lamp examination, fundus examinations, and Fundus fluorescein angiography were done. Diabetic Retinopathy was graded using a modified ETDRS grading system. Laboratory investigations included complete blood count, fasting and postprandial blood sugar, lipid profile, renal function test, and Hb1AC levels, providing a thorough assessment of patients’ ocular and systemic health.Result: Out of the 200 diabetics, 43.5% had diabetic retinopathy, with a slightly higher prevalence in males (44.64%) compared to females. The age group 50 - 59 had the highest prevalence (74.19%), and Hindus, Muslims, and other communities showed comparable percentages. Family history and hypertension were significant factors, with 88% of those with a family history developing retinopathy. NPDR was predominant (87.35%), while 12.64% had PDR. Clinically Significant Macular Edema (CSME) was present in 59.77%, with 80.76% of these cases having concomitant hypertension. Conclusion: The study emphasizes the imperative for early detection and comprehensive management of diabetic retinopathy among newly diagnosed diabetics. Age, gender, family history, and hypertension emerge as crucial determinants, advocating for integrated care and targeted screening programs to safeguard vision.
0000-0003-4281-1787 
